Thermo Fisher Scientific Inc. (TMO): What is Its Dividend Yield?

0
5

Thermo Fisher Scientific Inc. (NYSE:TMO) saw a downside of -3.98% to close Tuesday at $580.72 after subtracting -$24.1 on the day. The 5-day average trading volume is 2,038,000 shares of the company’s common stock. It has gained $609.85 in the past week and touched a new high 3 times within the past 5 days. An average of 1,751,530 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,581,006.

TMO’s 1-month performance is 7.56% or $40.04 on its low of $522.78 reached on 01/06/23. The company’s shares have touched a 52-week low of $475.77 and high of $618.35, with the stock’s rally to the 52-week high happening on 01/24/23. YTD, TMO has achieved 5.45% or $30.03 and has reached a new high 9 times. However, the current price is down -6.09% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Insider Transactions

TMO stock investors last saw insider trading activity on Dec 15.Spar Debora L (Director) most recently sold 200 shares at $561.39 per share on Dec 15. This transaction cost the insider $112,278. Executive Vice President, Pettiti Gianluca, sold 2,000 shares at a price of $569.11 on Dec 14. Then, on Dec 13, Executive Vice President Pettiti Gianluca sold 4,975 shares at a price of $576.84 per share. This transaction amounted to $2,869,779.

Valuation Metrics

TMO stock has a beta of 0.80. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 5.07 while the price-to-book (PB) in the most recent quarter is 5.23, with the price to cash flow ratio at 43.42.

Thermo Fisher Scientific Inc.’s quick ratio for the period ended September 29 was 1.20, with the current ratio over the same period at 1.70. As well, the company’s long term debt to equity for the quarter ending September 29 was 0.65, while the total debt to equity was 0.67.. In terms of profitability, the gross margin trailing 12 months is 44.40%. The firm’s gross profit as reported stood at $19.64 billion against revenue of $39.21 billion.

Earnings Surprise

For the quarterly period ending September 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -27.22% to $1.5 billion, while revenue of $1.66 billion was -11.3% off the previous quarter. Analysts expected TMO to announce $4.81 per share in earnings in its latest quarter, but it posted $5.08, representing a 5.60% surprise. EBITDA for the quarter stood at more than $2.55 billion. TMO stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 46.93 billion, with total debt at $29.16 billion. Shareholders hold equity totaling $392.2 million.

Let’s look briefly at Thermo Fisher Scientific Inc. (TMO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 24 January was 53.80% to suggest the stock is trending Neutral, with historical volatility in this time period at 29.62%.

The stock’s 5-day moving average is $588.62, reflecting a -1.21% or -$7.14 change from its current price. TMO is currently trading +7.71% above its 20-day SMA, +4.77% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +19.81% and SMA200 by-1.14%.

Stochastic %K and %D was 85.72% and 87.30% and the average true range (ATR) pointed at 17.09. The RSI (14) points at 55.64%, while the 14-day stochastic is at 66.54% with the period’s ATR at 16.14. The stock’s 9-day MACD Oscillator is pointing at 6.52 and 18.29 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Thermo Fisher Scientific Inc. (NYSE: TMO), Deutsche Bank launched coverage with a Buy rating. Analysts offering their rating for TMO stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate TMO as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 3 rates the stock as overweight while 16 have offered a “buy” rating.

What is TMO’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $505.00 and a high of $710.00, with their median price target at $620.00. Looking at these predictions, the average price target given by analysts is for Thermo Fisher Scientific Inc. (TMO) stock is $623.89.

LEAVE A REPLY

Please enter your comment!
Please enter your name here